Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza

PHASE4CompletedINTERVENTIONAL
Enrollment

1,742

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

November 30, 2009

Conditions
InfluenzaAcute Respiratory Infection
Interventions
BIOLOGICAL

Influenza vaccine

"Influenza vaccine: schoolchidren in the experimental group received IM administered:~* From 6 to 9 years of age - 2 doses (0.5ml each) of the tri-valent innactivated influenza vaccine - Southern Hemisphere formulation, 2009 - one month apart.~* 9 years of age and older: one dose (0.5ml) of the tri-valent innactivated influenza vaccine - Southern Hemisphere formulation, 2009 - one month apart."

BIOLOGICAL

Control vaccine

"Schoolchildren from 6 to 8 years of age:~\- One dose (0.5ml), IM administered, of Meningococcal C conjugate vaccine, and one dose (0.5ml), one month later, of varicella vaccine, IM administered."

Trial Locations (1)

05503900

Butantan Institute, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Butantan Institute

OTHER_GOV